OOIR: Observatory of International Research

Papers

(The TQCC of Southern African Journal of HIV Medicine is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Weight gain in children from birth to 10 years on antiretroviral treatment	17
Late-onset efavirenz toxicity: A descriptive study from Pretoria, South Africa	15
Where are the children? Case finding in 5–14-year-olds living with HIV in Johannesburg	15
A multidisciplinary approach for people with HIV failing antiretroviral therapy in South Africa	14
Retrospective review of maternal HIV viral load electronic gatekeeping codes in South Africa	13
Doxycycline post-exposure prophylaxis for sexually transmitted infections in South Africa	12
The 96-week outcomes and pharmacokinetics of long-acting cabotegravir plus rilpivirine in South Africans	12
Social support experiences of adolescents living with perinatal HIV in rural Limpopo, South Africa	10
Cutaneous squamous cell carcinoma in vertically acquired HIV and epidermodysplasia verruciformis	10
Rural nurses’ antiretroviral prescribing practices in children, Limpopo province, South Africa	10
Hepatitis B seroprevalence among HIV-positive adults in the Free State, South Africa	9
Confronting the human papillomavirus–HIV intersection: Cervical cytology implications for Kenyan women living with HIV	9
Management of drug-induced liver injury in people with HIV treated for tuberculosis: 2024 update	9
Cytomegalovirus retinitis and antiretroviral treatment: A fifteen year experience	8
Using creativity and the arts to promote mental health in youth living with HIV in South Africa	8
The sexual and reproductive health needs of young people living with HIV in Gauteng, South Africa	7
Rifampicin resistance and mortality in patients hospitalised with HIV-associated tuberculosis	7
Acknowledgement to reviewers	7
COVID-19 and HIV viral load suppression in children and adolescents in Durban, South Africa	7
Tracking viral control in adolescents on antiretroviral therapy in Lusaka, Zambia: A retrospective cohort analysis	6
COVID-19 severity and in-hospital mortality in an area with high HIV prevalence	6
Interpersonal relations of pregnant women post-HIV diagnosis in Thembisile Hani, South Africa	6
Radiological predictors of PCP in HIV-positive adults in South Africa: A matched case-control study	6
High paediatric HIV viral load rejection rate in South Africa, a retrospective review	5
Causes of death in adults living with HIV in South Africa: A single-centre postmortem study	5

Effect of dolutegravir on ferritin, iron, and C-reactive protein among people living with HIV and co-infections	5
Steatotic liver disease in people with HIV at Tshepong Hospital: A post-mortem analysis	5
Effect of a ward-based outreach team and adherence game on retention and viral load suppression	5
Acceptability and performance of dual HIV/syphilis testing in male circumcision clients, 2021	5
Pharmacokinetics, pharmacogenetics, and toxicity of co-administered efavirenz and isoniazid	5
South African harm reduction guideline for chemsex	4
Table of Contents Vol 24, No 1 (2023)	4
Factors influencing the high rejection rates of HIV 1/2 serology samples at Charlotte Maxeke Johannesburg Academic Hospital and the cost implications	4
The prevalence of multimorbidity in virally suppressed HIV-positive patients in Limpopo	4
Transition of adolescents from paediatric to adult HIV care in South Africa: A policy review	4
Oral pre-exposure prophylaxis uptake, adherence, and adverse events among South African men who have sex with men and transgender women	4
Alere Determine-tuberculosis lipoarabinomannan positivity in disseminated non-tuberculous mycobacteria: An illustrative case series	4
Tracking adverse drug reactions and medication errors in the Central Chronic Medicine Dispensing and Distribution (CCMDD) programme in South Africa	4
Southern African HIV Clinicians Society 2022 guideline for the management of sexually transmitted infections: Moving towards best practice	4